Precision Medicine Market Size | Growth Insights, Trends & Share 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10454

Publication Date: Nov 2025

What is the size of Precision Medicine Market?

According to 6Wresearch internal database and industry insights, the Global Precision Medicine Market was valued at USD 14.5 Billion in 2024 and is expected to reach USD 34 Billion by 2031, growing at a compound annual growth rate of 13.10% during the forecast period (2025-2031).

The main drivers of this growth are the growing integration of AI in genomics, personalized treatment plans for chronic diseases, increased focus on targeted therapeutics, and rapid advancements in molecular diagnostics.

Growth Factors for Precision Medicine Industry

Increasing demand for individualized therapies for complex and chronic diseases.
Advancements in genomic sequencing and molecular profiling.
Rising investment in biotechnology and healthcare R&D.
Expanding applications of AI and big data analytics in diagnostics.
Supportive government policies promoting personalized healthcare solutions.

Precision Medicine Market Trends

Precision Medicine Market trends highlight an increasing dependence on genomics and data-driven insights to inform the development of targeted therapeutics. The adoption of next-generation sequencing (NGS) and biomarker discovery tools is increasing in use among researchers and providers. Furthermore, cloud-enabled data storage, wearable devices, and AI-enabled diagnostic tools are changing the manner in which health care is delivered to patients. Pharmaceutical companies are also developing new collaborations for comorbid studies to expedite precision medicine therapies and improve health outcomes.

View Main Report

Schedule Analyst Call

Emerging Developments in the Precision Medicine Market

Precision Medicine Market developments include the growing integration of bioinformatics platforms, which can enhance patient data analysis for interpretations and decisions. Multi-omics approaches like genomics, proteomics, and metabolomics are being used in this field to deepen understanding of the biology of disease. The partnerships for new technology firms and pharmaceutical companies are also increasing to hasten precision pharmacology. There are also rapid advances in clinical trials driven by AI and predictive analytics to further our ability to develop personalised therapy that better considers genetics and lifestyle factors.